xAnts

Alphabet's AI-Powered Drug Development: A Game-Changer Ahead of Earnings?

As Alphabet prepares to release its earnings, experts weigh in on the company's AI-driven drug development potential. Big Technology's Alex Kantrowitz joins CNBC's Deirdre Bosa and Wealth Enhancement's Ayako Yoshioka to discuss the impact of artifici ...Read more